Enveric Biosciences, Inc. (ENVB)

Price & Market Data

Price: $2.19

Daily Change: -$0.03 / 1.37%

Daily Range: $2.10 - $2.36

Market Cap: $8,136,964

Daily Volume: 116,605

Performance Metrics

1 Week: 3.01%

1 Month: -30.08%

3 Months: 9.36%

6 Months: -60.62%

1 Year: -84.49%

YTD: -36.08%

About Enveric Biosciences, Inc. (ENVB)

In-depth market report for Enveric Biosciences, Inc. (ENVB). The stock is valued at 2.19, with a daily change of -$0.03 / 1.37%. Market cap: 8,136,964. All key performance metrics are updated, including YTD and 52-week returns.

Company Details

Employees: 6

Sector: Health technology

Industry: Pharmaceuticals: other

Country: United States

Details

Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.

Selected stocks

Recursion Pharmaceuticals, Inc. (RXRX)

Arbutus Biopharma Corporation (ABUS)

Inuvo, Inc. (INUV)

Grab Holdings Limited (GRAB)

Western Copper and Gold Corporation (WRN)